Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 65219-512

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 65219-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fresenius Kabi Logo (Pot13 0000 01)

FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Vial Label)

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Vial Label)
This text provides information about a Pharmacy Bulk Package of Potassium Acetate Injection (100 mEq/50 mL) for intravenous use. It includes details on dilution requirements, dosage information, pH levels, storage conditions, and cautionary instructions on use. The product is intended for preparing intravenous admixtures under aseptic conditions and is not for direct infusion. The manufacturer is Fresenius Kabi based in Lake Zurich, IL.*
FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Tray Label)

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 50 mL Tray Label)
This is a description of Potassium Acetate Injection, USP with a concentration of 100 mEq/50 mL. It is a Pharmacy Bulk Package meant for intravenous use, which needs to be diluted before use. Each mL contains 196 mg of potassium acetate and may also contain acetic acid for pH adjustment. The solution has a pH of 6.2 (range 5.5 to 8.0) and a calculated osmolality of 4 mOsmol/mL. Proper aseptic techniques are required for admixture preparation and should be stored at 20 to 25°C. The package insert should be consulted for complete dosage information and administration guidelines.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.